Carisma Therapeutics Inc., a clinical-stage biopharmaceutical company focused on discovering and developing immunotherapies, has appointed Eugene P. Kennedy, M.D., F.A.C.S. as the company’s Chief Medical Officer.   Kennedy brings over 15 years of clinical and industry experience, including cross-functional leadership driving clinical development and regulatory strategies for oncology and immuno-oncology focused organizations. As Chief Medical Officer, he will be responsible for overseein...